XML 88 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments
Note 16. Fair Value of Financial Instruments
Certain of the Company’s financial assets and liabilities are measured at fair value on a recurring and nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or the price paid to transfer a liability (the exit price) in the principal and most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities carried at fair value are classified using the following three-tier hierarchy:
Level 1: Quoted market prices in active markets for identical assets or liabilities;
Level 2: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and
Level 3: Fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The following table summarizes the valuation of the Company’s foreign currency forward contracts (see Note 17) that are measured at fair value on a recurring basis by the above pricing levels at March 31, 2020 and December 31, 2019 (in thousands):
 
Fair
Value
 
Level 1
 
Level 2
 
Level 3
March 31, 2020
 
 
 
 
 
 
 
Foreign currency forward contracts—asset position
$
7,109

 
$

 
$
7,109

 
$

Foreign currency forward contracts—liability position
(1,888
)
 

 
(1,888
)
 

 
 
 
 
 
 
 
 
Interest rate hedge agreements—liability position
(19,690
)
 

 
(19,690
)
 

 
$
(14,469
)
 
$

 
$
(14,469
)
 
$

December 31, 2019
 
 
 
 
 
 
 
Foreign currency forward contracts—asset position
$
61

 
$

 
$
61

 
$

Foreign currency forward contracts—liability position
(766
)
 

 
(766
)
 

 
 
 
 
 
 
 
 
Cross-currency debt swap agreements—asset position
6,163

 

 
6,163

 

Cross-currency debt swap agreements—liability position
(25
)
 

 
(25
)
 

 
 
 
 
 
 
 
 
Interest rate hedge agreements—asset position
(8,894
)
 

 
(8,894
)
 

 
$
(3,461
)
 
$

 
$
(3,461
)
 
$


The fair value of the Company’s foreign currency forward contracts and cross-currency debt swap contracts are based on observable inputs that are corroborated by market data. Observable inputs include broker quotes, daily market foreign currency rates and forward pricing curves. Remeasurement gains and losses on foreign currency forward contracts and cross-currency debt swap contracts designated as cash flow hedges are recorded in accumulated other comprehensive income (loss) until recognized in earnings during the period that the hedged transactions take place. The fair value of interest rate hedge contracts are based on observable inputs that are corroborated by market data. Observable inputs include daily market foreign currency rates and interest rate curves. Remeasurement gains and losses are recorded in accumulated other comprehensive income (loss) until recognized in earnings as interest payments are made or received on the Company’s variable-rate debt. Remeasurement gains and losses on foreign currency forward contracts that are not-designated as cash flow hedges are recorded in other income (expense) (see Note 17).
Disclosures about the Fair Value of Financial Instruments
The carrying values of cash and cash equivalents at March 31, 2020 and December 31, 2019 are categorized within Level 1 of the fair value hierarchy. The table below summarizes information about fair value relating to the Company’s financial assets and liabilities that are recognized in the accompanying consolidated condensed balance sheets as of March 31, 2020 and December 31, 2019, as well as the fair value of contingent contracts that represent financial instruments (in thousands).
 
March 31, 2020
 
December 31, 2019
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
 
Fair 
Value
Term Loan Facility(1)
$
445,200

 
$
411,810

 
$
446,400

 
$
450,864

Primary Asset-Based Revolving Credit Facility(2)
$
300,257

 
$
300,257

 
$
114,480

 
$
114,480

Japan ABL Facility(2)
$
35,336

 
$
35,336

 
$
30,100

 
$
30,100

Equipment notes(3)
$
28,283

 
$
28,283

 
$
19,715

 
$
19,715

Standby letters of credit(4)
$
1,375

 
$
1,375

 
$
1,075

 
$
1,075

 

(1)
In January 2019, the Company entered into the Term Loan Facility. The fair value of this debt is categorized within Level 2 of the fair value hierarchy. The fair value of the Term Loan Facility as of March 31, 2020 was affected by volatile market conditions resulting from to the COVID-19 pandemic. See Note 6 for further information.
(2)
The carrying value of the amounts outstanding under the Company's ABL Facility and Japan ABL Facility approximates the fair value due to the short-term nature of these obligations. The fair value of this debt is categorized within Level 2 of the fair value hierarchy based on the observable market borrowing rates. See Note 6 for information on the Company's credit facilities, including certain risks and uncertainties related thereto.
(3)
In December 2017, August 2019 and March 2020, the Company entered into equipment notes that are both secured by certain equipment at the Company's golf ball manufacturing facility. The fair value of this debt is categorized within Level 2 of the fair value hierarchy. See Note 6 for further information.
(4)
The carrying value of the Company's standby letters of credit approximates the fair value as they represent the Company’s contingent obligation to perform in accordance with the underlying contracts, using the exchange rates in effect at March 31, 2020 and December 31, 2019. As such, the fair value of this contingent obligation is categorized within Level 2 of the fair value hierarchy.
Nonrecurring Fair Value Measurements
The Company measures certain assets at fair value on a nonrecurring basis at least annually or more frequently if certain indicators are present. These assets include long-lived assets, goodwill, non-amortizing intangible assets and investments that are written down to fair value when they are held for sale or determined to be impaired. During each of the three months ended March 31, 2020 and 2019, there were no impairments recorded related to the Company's assets that are measured at fair value on a nonrecurring basis. Assets purchased in connection with the acquisitions of Jack Wolfskin were valued at their fair value on the date of purchase (see Note 5).